Anagrelide HCl Anagrelide (BL-4162A) is a drug used for the treatment of essential thrombocytosis. In vitro
Anagrelide is an oral imidazoquinazoline agent with an anti-cyclic AMP phosphodiesterase activity and inhibits platelet aggregation in both humans and animals. Anagrelide works by inhibiting the maturation of platelets from megakaryocytes.